December 14, 2018 Since the Administration released its drug pricing proposal (the "blueprint") earlier this year, virtually all health care stakeholders have engaged in robust discussions about the specific policies contained in the plan. The National Alliance has provided its members with updates, submitted comment letters, and continued to follow national discussions on drug pricing issues. This viewpoint summarizes specific proposals and offers insights from a purchaser perspective.
National Alliance of Healthcare Purchaser Coalitions1015 18th Street, NW, Suite 705Washington, DC 20036(202) 775-9300 (phone)(202) 775-1569 (fax)
National Alliance WebsiteJoinWhat We DoContact UsTerms and Conditions